LifeQ Global Limited

Based in the US, LifeQ Global Limited develops advanced biometric intelligence solutions that offer comprehensive health monitoring through innovative wearable technology. Founded in 2014 in Alpharetta, US, LifeQ Global Limited focuses on biometric intelligence and health monitoring solutions. The company has undergone strategic growth, garnering attention for its significant funding activities. Laurie Olivier and Riaan Conradie co-founded the company.

The most recent funding round, a Series A, raised USD 47. 00 mn on May 26, 2021, led by OneBio Venture Studio, with participation from various investors including 4Di Capital and Analog Devices. LifeQ specializes in biometric intelligence and wearable technology that deliver comprehensive health monitoring solutions. Its core offerings provide access to over 150 physiological biomarkers through non-invasive disease screening and real-time biometric feedback, aimed at optimizing health and longevity.

The products cater to individuals, healthcare providers, and corporate entities, focusing on a preventative approach to health management. Wearable devices are validated by scientific algorithms that analyze collected data, offering personalized health insights and recommendations, marketed globally with significant presence in North America, Europe, and Asia-Pacific. LifeQ generates revenue primarily through B2B and direct-to-consumer transactions, partnering with healthcare providers, telemedicine platforms, and corporate wellness programs. The revenue model includes subscription-based services for ongoing access to health monitoring solutions and sales of its flagship wearable devices.

Tailored packages integrate LifeQ’s technology with existing health initiatives, enhancing patient outcomes while accommodating various market segments. Following its recent Series A funding of USD 47. 00 mn, LifeQ Global Limited plans to enhance its offerings in remote health monitoring. This funding will support the development of upcoming products designed for expanded health insights and capabilities.

The company is targeting strategic expansion into new markets, particularly in North America and Europe, aiming to broaden its reach by the end of 2023, leveraging the demand for innovative health monitoring solutions.